IL159230A0 - Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance - Google Patents

Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance

Info

Publication number
IL159230A0
IL159230A0 IL15923002A IL15923002A IL159230A0 IL 159230 A0 IL159230 A0 IL 159230A0 IL 15923002 A IL15923002 A IL 15923002A IL 15923002 A IL15923002 A IL 15923002A IL 159230 A0 IL159230 A0 IL 159230A0
Authority
IL
Israel
Prior art keywords
methods
progenitor cells
hematopoietic progenitor
immunological tolerance
inducing immunological
Prior art date
Application number
IL15923002A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL159230A0 publication Critical patent/IL159230A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15923002A 2001-06-18 2002-06-18 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance IL159230A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/881,721 US20030147859A1 (en) 2001-06-18 2001-06-18 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
PCT/IL2002/000476 WO2002102971A2 (en) 2001-06-18 2002-06-18 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance

Publications (1)

Publication Number Publication Date
IL159230A0 true IL159230A0 (en) 2004-06-01

Family

ID=25379057

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15923002A IL159230A0 (en) 2001-06-18 2002-06-18 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance

Country Status (5)

Country Link
US (2) US20030147859A1 (de)
EP (1) EP1414305A4 (de)
AU (1) AU2002311610A1 (de)
IL (1) IL159230A0 (de)
WO (1) WO2002102971A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US20030147859A1 (en) * 2001-06-18 2003-08-07 Yair Reisner Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
EP2946666B1 (de) 2004-04-30 2017-11-15 OrbusNeich Medical, Inc. Medizinische vorrichtung mit beschichtung zur erfassung von genetisch veränderten zellen und anwendungsverfahren dafür
ES2763537T3 (es) * 2008-09-16 2020-05-29 Beckman Coulter Inc Diagrama de árbol interactivo para datos de citometría de flujo
RU2506311C2 (ru) 2008-10-30 2014-02-10 Йеда Рисёрч Энд Девелопмент Ко. Лтд. Т-клетки центральной памяти против третьей стороны, способы их получения и их применение в трансплантации и лечении заболеваний
EP2613801B1 (de) 2010-09-08 2016-06-08 Yeda Research and Development Co. Ltd. Zentrale anti-dritte-t-gedächtniszellen, und deren verwendung in einer 'anti-leukämie/lymphoma' behandlung
EP2753351B1 (de) 2011-09-08 2017-06-21 Yeda Research and Development Co. Ltd. Zentrale anti-dritte-t-gedächtniszellen, verfahren zur herstellung davon und verwendung davon in der transplantation und bei der krankheitsbehandlung
US10933124B2 (en) 2015-07-16 2021-03-02 Yeda Research And Development Co. Ltd. Methods of transplantation and disease treatment
JP7334043B2 (ja) 2016-06-27 2023-08-28 イェダ リサーチ アンド ディベロップメント カンパニー リミテッド メモリーｔ細胞から作られるベト細胞
US10751368B2 (en) 2017-01-18 2020-08-25 Yeda Research And Development Co. Ltd. Methods of transplantation and disease treatment
EP3571295A1 (de) 2017-01-18 2019-11-27 Yeda Research and Development Co. Ltd Genetisch modifizierte vetozellen und verwendung davon in der immuntherapie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
DE69841058D1 (de) * 1997-11-14 2009-09-24 Gen Hospital Corp Behandlung von hämatologischen störungen
US20030147859A1 (en) * 2001-06-18 2003-08-07 Yair Reisner Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance

Also Published As

Publication number Publication date
US20030147859A1 (en) 2003-08-07
WO2002102971A2 (en) 2002-12-27
EP1414305A4 (de) 2005-10-05
US20050232904A1 (en) 2005-10-20
EP1414305A2 (de) 2004-05-06
WO2002102971A3 (en) 2004-03-04
AU2002311610A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AU2003295444A8 (en) Methods for in vitro expansion of hematopoietic stem cells
AU6842001A (en) Pluripotent mammalian cells
EP1447091A4 (de) Neues verfahren zur induktion von antigen-spezifischen t-zellen
IL214970A (en) Methods to encourage embryonic progenitor differentiation
EP1424389A4 (de) Verfahren zur herstellung hämatopoetischer stammzellen
IL161858A0 (en) Cell culture process
EP1447092A4 (de) Neues verfahren zur induktion von antigenspezifischen t-zellen
PL377731A1 (pl) Sposoby hodowli komórek ssaczych do wytwarzania białka
AU2002356749A1 (en) Process for the production of polypeptides in mammalian cell cultures
IL159580A0 (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
EP1325953A4 (de) Methode zur kultivierung von mesenchymalen stammzellen
HUP0500161A3 (en) Methods to culture circovirus
IL159230A0 (en) Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
EP1725656A4 (de) Serumfreies suspensionskultursystem fürmesenchym-vorläuferzellen
EP1312670A4 (de) Methode zur extensiven kultur von antigen-spezifischen cytotoxischen t-zellen
WO2004035132A3 (en) Compositions and methods for inducing osteogenesis
HK1048650A1 (zh) 在細胞培養物中增強細胞激動素(cytokines)的方法
AU2003277274A1 (en) Ultrasound-assisted desulfurization of fossil fuels in the presence of diakyl ethers
IL162343A0 (en) Cell constructs cultured in vitro, preparation anduses
EP1445311A4 (de) Verfahren zur amplifikation hämatopoetischer stammzellen
AU2002309330A1 (en) Isolation method of mesenchymal cells
IL146970A0 (en) Migration of haematopoietic stem cells and progenitor cells to the liver
EP1597356A4 (de) Antigenpräsentierende cd14+-kulturzellen
AU2001280368A1 (en) Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
AU2002239424A1 (en) Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients